Lesly Giovanna Maldonado-Burbano

Lesly Giovanna Maldonado-Burbano

Auto-generated profile, based on publicly available information

Lesly Giovanna Maldonado-Burbano

Saint Martin University

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2026 in Health Care & Global Health
Verified
Journal Article
Open access
PDF file
DMDanuil Julián Melo-Ascanio
Danuil Julián Melo-Ascanio
MPMaria Alejandra Palacios-Rodríguez
Maria Alejandra Palacios-Rodríguez
LMLesly Giovanna Maldonado-Burbano
Lesly Giovanna Maldonado-Burbano
JAJuan Camilo Arias-Pérez
Juan Camilo Arias-Pérez
VBValentina Bravo-Echeverry
Valentina Bravo-Echeverry
ACAntonio José Carvajal-Mazuera
Antonio José Carvajal-Mazuera
Type 2 diabetes mellitus (T2DM) poses increasing perioperative challenges due to the widespread use of modern antidiabetic therapies with cardiometabolic, renal, and weight-related benefits, but also specific anesthetic and metabolic safety implications. This narrative review integrated clinical, pharmacological, and perioperative evidence on glucagon-like peptide-1 receptor agonists (GLP-1RA), dual GIP/GLP-1 agonists, and sodium-glucose cotransporter-2 inhibitors (SGLT2i). GLP-1RA and dual GIP/GLP-1 agonists are associated with delayed gastric emptying and increased residual gastric content, although their relationship with clinically significant pulmonary aspiration remains uncertain. Gastric ultrasound may support individualized risk stratification in selected settings. Conversely, SGLT2i are linked to euglycemic diabetic ketoacidosis, particularly during fasting, surgery, infection, dehydration, or carbohydrate restriction, requiring preoperative discontinuation, metabolic surveillance, and delayed reinitiation until clinical stability, euvolemia, and oral tolerance are achieved. Perioperative care in T2DM should move beyond a glucose-centered approach and incorporate medication reconciliation, multidisciplinary assessment, and individualized decision-making based on anesthetic, metabolic, and surgical risk. Keywords: Diabetes Mellitus, Type 2; Perioperative Care; Glucagon-Like Peptide-1 Receptor Agonists; Sodium-Glucose Transporter 2 Inhibitors; Diabetic Ketoacidosis (Source: MeSH, NLM).